Professor Shaun Larkin is a part-time academic at the School of Public Health , University of Sydney, specializing in Health Policy and Financing . He is affiliated with the Leeder Centre for Health Policy, Economics and Data and a member of the Charles Perkins Centre . With a career spanning executive roles at HCF and non-executive directorships in health startups, his work bridges academia and industry. Education : Harvard Business School alumnus with a HlthScD, MBA, MHSc, and BHA. His research focuses on health economics , health policy , and health services management , emphasizing: Translational research in healthcare financing Trends in private-public healthcare partnerships Price transparency in private health insurance Leadership in health systems Chronic disease management Quality use of medicines His publications reveal a trajectory from foundational work in: Psychiatric services data standardization (2000) Heart disease and diabetes management (2013-2015) Telehealth interventions (2017-2018) Private sector policy frameworks (2019-2020) Saudi Arabian health reforms (2022-present) Private equity in healthcare (2025) As an advisor, he currently supervises research students on topics including: Quality use of medicines in Saudi Arabia Sustainable financial models for private hospitals Patient-reported outcome measures in Australia He also contributes to the Leeder Centre and engages with global health startups as an investor and advisor.
Bernadka Dubicka is a Clinical Professor and Honorary Clinical Chair in the Division of Neuroscience at the University of Manchester. She holds dual roles as a research lead at Pennine Care NHS Foundation Trust and as the child and adolescent mental health research lead for Health Innovation Manchester. She is the Editor-in-Chief of the Journal of Child and Adolescent Mental Health and previously served as Chair of the Child and Adolescent Faculty at the Royal College of Psychiatrists (2017–2021). Her academic qualifications include a BSc in Psychology and MBBs from University College London, followed by FRCPsych accreditation in child psychiatry. She earned a gold medal for her MD thesis on behavioral disorder implications in depression. Dubicka’s research focuses on adolescent depression, mood disorders, and brief interventions, including the IMPACT and STADIA trials evaluating psychological treatments and standardized diagnostic assessments. Her work also addresses technology’s role in youth mental health and the eco-crisis’s mental health impacts. Education: BSc Psychology, University College London MBBs, University of London MD Thesis (Gold Medal), University College London FRCPsych, Royal College of Psychiatrists Her research spans depression treatment efficacy, behavioral activation, and cross-national studies on pediatric bipolar disorder. She collaborates internationally and has led over 49 publications. Awards include a gold medal for her thesis and recognition as an RCPsych Fellow. Her work also emphasizes policy advocacy, such as addressing digital rights for children and mental health responses to climate change (e.g., COP26 contributions). She trains clinicians in brief psychosocial interventions and behavioral activation through academic programs and national courses. Grants & Funding: Co-investigator on the £1.1M HTA-funded STADIA trial evaluating remote mental health assessments. Principal investigator on the IMPACT trial, one of the largest adolescent depression trials globally. Labs/Teams: Collaborations include the University of Cambridge (IMPACT trial), University of Nottingham (STADIA), and international taskforces on treatment-resistant depression.
Professor Emily So serves as Deputy Head of the School of Arts and Humanities at the University of Cambridge and directs the Cambridge University Centre for Risk in the Built Environment (CURBE). A chartered civil engineer with extensive field experience, she holds leadership roles in the Open-Oxford-Cambridge AHRC Doctoral Training Partnership and chairs the Faculty EDI Committee. Her research focuses on urban risk and resilience , particularly in earthquake-prone regions. Combining structural engineering with epidemiological approaches, she develops innovative casualty estimation models and engages directly with affected communities worldwide. Her work spans seismic safety, disaster epidemiology, and remote sensing applications for rapid damage assessment. Professor So's publication trends reveal strong emphasis on machine learning for disaster risk modeling , with recent work featuring graph neural networks, deep clustering for urban morphology, and LSTM-based population forecasting. Her research bridges engineering, social sciences, and data science to address resilience in developing nations. 2010 Shah Family Innovation Prize (Earthquake Engineering Research Institute) Fellow of the Institution of Civil Engineers (FICE) Scientific Advisory Group for Emergencies (SAGE) member advising UK government As Director of CURBE, she leads interdisciplinary collaborations with EEFIT, Global Earthquake Model (GEM), World Bank, and USGS. Her field investigations following major earthquakes inform practical solutions for vulnerable communities, notably contributing to the 2017 World Building of the Year design in China. Current work includes sabbatical research for 2025-2026 focused on decolonizing architectural approaches to disaster resilience. Professor So maintains active roles in professional organizations and international disaster response frameworks, with her CURBE team developing methodologies now implemented globally for seismic safety improvements.
Alena Thiel is an Associate Professor at the Centre of African Studies within the Faculty of Social Sciences at the University of Copenhagen. Her research examines digital technologies' impact on state formation and knowledge systems across Africa, with primary field sites in Ghana, Senegal, Botswana, and Kenya. Her core research areas include: State knowledge systems (biometric ID, census histories, DHIS2 health records) Digital governance (addressing systems, payment solutions, disaster risk datafication) African/feminist AI development and implementation Anthropology of the state through Science and Technology Studies (STS) frameworks Recent publications (2024-2025) reveal concentrated analysis of health data infrastructures in Ghana, trust dynamics in Africa's global networks, and critical sociological examinations of digital identification. Her work consistently bridges anthropological theory with practical governance challenges in African contexts. As an active member of the Centre of African Studies, she maintains interdisciplinary collaborations across multiple African countries and European institutions, with particular emphasis on Ghanaian research partnerships and editorial leadership for Africa Spectrum journal.
Dr. Karin A. King is an LSE Fellow in the Department of Management at the London School of Economics and Political Science (LSE). Her expertise spans global talent management, leadership development, and strategic human resource management. She teaches in LSE's Master's programs, focusing on organisational behaviour, negotiations, and strategic rewards. With over two decades of experience in corporate HR and consulting, Dr. King advises leaders on evidence-based talent management practices aligned with business priorities. Her research explores global talent systems, leadership succession, and diversity in organisational contexts. Dr. King has been recognized with multiple awards, including the LSE Teaching Award (2023), Top Ten Best Lecturer (2022), and repeated Teaching Excellence Awards (2015–2022). She holds professional certifications in HR, management consulting, and is a Fellow of the Higher Education Academy. Her work bridges academic research and practice, with publications in leading journals like BRQ Business Research Quarterly and Journal of Global Mobility . Recent research emphasizes macro-contingent talent strategies and the role of line managers in global talent initiatives.
Avinash V. Ramprashad serves as an Assistant Professor in the Department of Psychiatry at the University of Maryland School of Medicine, with clinical practice based at the University of Maryland Treatment Center. His educational background includes: Bachelor of Arts in Psychology from New York University (2011) Doctor of Medicine from SUNY Upstate Medical University COM, Syracuse, NY (2016) General Psychiatry Residency at University of Maryland/Sheppard Pratt (2020) Addiction Psychiatry Fellowship at University of Maryland (2021) Washington Baltimore Center for Psychoanalysis Fellowship Program (2020) Dr. Ramprashad specializes in addiction psychiatry with deep expertise in substance use disorders and evidence-based treatments including buprenorphine and methadone management. His clinical work integrates psychodynamic psychotherapy with innovative telemedicine applications, particularly in tele-addictions and tele-buprenorphine services, expanding access to care for underserved populations. He actively contributes to medical education and psychotherapy research within academic psychiatry. His professional recognition includes: George Balis Award for Excellence in Medical Student Education (2018) Dr. Donald Ross Award for Outstanding Psychotherapy Paper (2020) As a member of the Maryland Addiction Consultation Service (MACS), he participates in statewide initiatives providing expert consultation on complex addiction cases while advancing telehealth implementation in psychiatric practice.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Linda Linton is an Advanced Practice Sports and Musculoskeletal Physiotherapist and Medical Educator at Queen Margaret University, with a career spanning over 25 years. She serves as clinical lead at FASIC Sport & Exercise Medicine Clinic for back, neck, and pelvic/hip conditions and supervises PhD students in aquatic therapy research. Her work bridges clinical practice, education, and research in injury prevention and rehabilitation. BSc(HONS) Physiotherapy (University of Ulster, 1994) PG Cert Sports Physiotherapy (Manchester Metropolitan University, 1997) MMACP (Glasgow Caledonian University, 2000) MSc Manual Therapy (Glasgow Caledonian University, 2005) PG Cert Diagnostic Musculoskeletal Ultrasonography (University East London, 2018) Injection Therapy (Queen Margaret University, 2022) Linton’s research focuses on running-related injury prevention, aquatic therapy for low back pain, and physical activity promotion. Her work includes scoping reviews on injury risk reduction practices, meta-analyses of exercise-based prevention programs, and qualitative studies on community aquatic therapy. She pioneered Prehabilitation for Runners Workshops and investigates neuromuscular training, gait re-education, and aquatic muscle activity patterns. Her publications span journals like Journal of Sports Rehabilitation , Physiotherapy , and Physical Therapy in Sport , with recent 2024-2025 studies addressing aquatic therapy mechanics, running injury prevention frameworks, and swimmer injury risk factors. She collaborates with Edinburgh Sports Medicine Research Network and Bath Research Centre in the IOC Research Centre. Linton supervises PhD students in aquatic therapy projects and integrates load management, strength training, and running biomechanics into her clinical education. Her work emphasizes practitioner-patient collaboration and evidence-based strategies to reduce injury risks across athletic populations.
Tracey Evans Chan is an Associate Professor and Director of the NUS Law Academy at the National University of Singapore's Faculty of Law. His expertise lies in biomedical law and ethics, with a focus on issues such as surrogacy, transplant ethics, and human-animal research. He has held significant roles, including a secondment to Singapore's Ministry of Health, where he contributed to the Human Biomedical Research Act 2015. He currently serves on the National Medical Ethics Committee and the Advisory Committee on Restricted Research under the same Act, and is a member of NUS's Institutional Review Board. Education: LLM (Harvard University) LLB (National University of Singapore) Research Interests: Chan's work bridges legal and ethical dimensions of biomedical advancements. Key areas include regulatory challenges in mitochondrial replacement technology, consent frameworks for minors, and the ethical implications of emerging medical technologies. His contributions to Singapore's legal committees reflect his commitment to balancing innovation with societal values. Publications & Trends: His recent works explore themes like advance care planning, the placebo effect in clinical practice, and cross-jurisdictional comparisons of healthcare dependency laws. These publications underscore his interdisciplinary approach to legal and biomedical challenges. Awards & Grants: No specific awards or grants are listed, but his policy contributions and academic output highlight his impactful work in regulatory frameworks. Advising & Teams: As a faculty member, he teaches courses like Medical Law and Ethics. His involvement in NUS's Institutional Review Board and Singapore's advisory committees demonstrates his role in shaping research ethics and healthcare policy.
Dr. Joey Paquet is a Tenured Associate Professor and Department Chair in the Department of Computer Science and Software Engineering at Concordia University in Montreal, Canada. He holds a PhD and specializes in research areas including Design and Implementation of Programming Languages, Context-Driven Computing, and Demand-Driven Computing. His work focuses on advancing programming paradigms and their applications in cybersecurity, distributed systems, and autonomic computing. Dr. Paquet is actively involved in thesis supervision across Computer Science and Software Engineering programs at both master's and doctoral levels. Research interests are centered around programming language design, particularly in demand-driven and context-aware systems. His contributions include frameworks like GIPSY and OpenISS, enabling scalable data processing and forensic computing. Recent work explores autonomic intent-driven networking, real-time gesture recognition, and IoT forensics. These efforts highlight his expertise in both theoretical constructs and practical implementations. His advising role supports students in MCompSc, MASc, and PhD programs. While specific grants are not detailed, his projects often involve interdisciplinary collaboration. Dr. Paquet is affiliated with platforms like LinkedIn and ResearchGate, reflecting an active academic presence. Key technical contributions include pioneering work on forensic computing backends, intent expression languages, and multimodal interaction systems. His research addresses challenges in cybersecurity, distributed systems, and service composition, with a focus on resilience and scalability.
Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.
Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.
Charles E. Leonard is an Associate Professor of Epidemiology at the Perelman School of Medicine , University of Pennsylvania. He holds affiliations with multiple Penn-based institutions, including the Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Institute for Translational Medicine and Therapeutics, Leonard Davis Institute, Institute on Aging, and Center of Excellence in Environmental Toxicology. Additionally, he serves as a Special Government Employee at the FDA and Honorary Lecturer at Muhimbili University of Health and Allied Sciences in Tanzania. Pharmacoepidemiology Post-market prescription drug safety Causal inference methods Real-world evidence generation Environmental health impacts on chronic disease Dr. Leonard’s research focuses on generating real-world evidence to address critical gaps in drug safety, particularly for: Population health effects of drug interactions Comparative safety of antidiabetes drugs Drug-induced sudden cardiac arrest Ambient temperature extremes and chronic disease Pharmacoepidemiology methods development His work is primarily funded by the National Institutes of Health (NIH) and has been recognized through multiple awards, including the 2024 Harold I. Feldman Distinguished Scholar Award and the 2020 Elected Fellow status at the International Society for Pharmacoepidemiology. He also contributes to curriculum development and student mentoring in Penn’s Graduate Group in Epidemiology and Biostatistics. 2024 – Harold I. Feldman Distinguished Scholar Award (Penn) 2024 – Ronald D. Mann Best Paper Award (ISPE) 2020 – Leadership Medallion (BPS) 2019 – Abraham G. Hartzema Distinguished Lecturer (University of Florida)
Alex Mouzakitis is a Lecturer in Physiotherapy within the Faculty of Health, Education and Society at the University of Northampton, where he contributes to the MSc Physiotherapy (Pre-registration) programme. He combines extensive clinical experience with innovative teaching methods to develop competent, reflective physiotherapy practitioners. Educational Background: BSc (Hons) in Physiotherapy, First-class, University of West Attica, Athens, Greece (2015) MSc in Musculoskeletal Healthcare and Rehabilitation, University College London (2016) Alex's research and teaching focus on cardiorespiratory physiotherapy and musculoskeletal rehabilitation , emphasizing clinical reasoning and the integration of simulation and digital tools in education. His experience in ICU settings during the COVID-19 pandemic solidified his expertise in managing complex, critically ill patients. He also explored shoulder joint biomechanics in his MSc dissertation, focusing on rotator cuff activation patterns. Although no peer-reviewed publications are listed, his academic and clinical work centers on evidence-based approaches to physiotherapy, particularly in cardiorespiratory care and professional development. He is currently working toward Fellowship Accreditation in Higher Education, reflecting his commitment to pedagogical excellence. Scientific Awards and Honors: Alex supervises student learning through module leadership and clinical instruction, though no formal advisees are listed. He has been instrumental in delivering key modules such as PHYM002: Evidence-Based Cardiorespiratory Physiotherapy and PHY3001: Developing Professionalism and Collaborative Practice . He also maintains active clinical practice as a cardiorespiratory physiotherapy specialist in a private clinic in Northamptonshire, ensuring his teaching remains grounded in real-world application. Alex is involved in curriculum development and simulation-based teaching, contributing to a dynamic and responsive learning environment. His interdisciplinary approach bridges clinical expertise with educational innovation, preparing students for the evolving healthcare landscape.
John P.A. Ioannidis is the C.F. Rehnborg Professor in Disease Prevention and Professor of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics at Stanford University. He is Co-Director of the Meta-Research Innovation Center at Stanford (METRICS) and an Einstein BIH Visiting Fellow at Charité - Universitätsmedizin Berlin. His academic appointments span multiple departments and institutes at Stanford, including the Stanford Prevention Research Center, Biomedical Data Science, and Statistics. He is internationally recognized for his work in meta-research, evidence-based medicine, and research reproducibility. Ioannidis holds an MD and DSc in Biopathology from the National University of Athens, with training in internal medicine and infectious diseases from Harvard and Tufts. He previously chaired the Department of Hygiene and Epidemiology at the University of Ioannina Medical School and held adjunct positions at Harvard, Tufts, and Imperial College. He joined Stanford in 2010, where he launched the PhD program in Epidemiology & Clinical Research, the MS in Community Health & Prevention Research, and METRICS in 2014. His research focuses on improving research methods, appraising biases, enhancing reproducibility, and integrating evidence across scientific disciplines. He is a pioneer in meta-research, with seminal contributions on the reliability of published findings, statistical practices, and research synthesis. His influential 2005 paper, "Why Most Published Research Findings Are False," is the most-accessed article in PLoS history. His recent work examines peer review, data sharing, AI in medicine, and pandemic research impact, consistently advocating for transparency and methodological rigor. His publications span epidemiology, statistics, genomics, clinical trials, and meta-analysis, with a strong emphasis on bias detection, replication, and open science. Trends in his recent articles highlight concerns about research integrity, citation practices, peer review reform, and the scientific response to global health crises. Founders' Medal for Lifetime Contributions to Meta-science (2024) Honorary doctorates from McMaster, Thessaloniki, Edinburgh, Tilburg, Athens, and Rotterdam Elected member, US National Academy of Medicine (2018) Elected member, European Academy of Sciences and Arts (2015) President, Association of American Physicians (2023–2024) President, Society for Research Synthesis Methodology Gordon Award, NIH (2019) Chanchlani Global Health Award (2017) Highly Cited Researcher (Clarivate) in Clinical Medicine, Social Sciences, and Psychiatry Ioannidis has advised numerous students and mentored early-career researchers. He has served as Senior Advisor for Knowledge Integration at the National Cancer Institute (2012–2016) and Editor-in-Chief of the European Journal of Clinical Investigation (2010–2019). He has received over 700 invited lectures and is deeply involved in shaping research policy and scientific infrastructure. He leads METRICS, a hub for meta-research innovation, and is affiliated with multiple Stanford institutes, including Bio-X, the Cardiovascular Institute, and the Stanford Cancer Institute.
